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Cutaneous Hypersensitivities to Hapten Are
Controlled by IFN-c-Upregulated Keratinocyte Th1
Chemokines and IFN-c-Downregulated Langerhans
Cell Th2 Chemokines
Tomoko Mori1, Kenji Kabashima1, Ryutaro Yoshiki1, Kazunari Sugita1, Noriko Shiraishi1, Ayako Onoue1,
Etsushi Kuroda2, Miwa Kobayashi1, Uki Yamashita2 and Yoshiki Tokura1
There are immediate, late-phase, and delayed-type reactions to exogenous agents. In IFN-g-knockout (IFN-g/)
and wild-type B6 mice, we examined the response to picryl chloride (PCl) for assessing delayed-type reactions,
and the responses to repeatedly challenged FITC for immediate and late-phase reactions. The delayed-type
hypersensitivity was depressed in IFN-g/ mice, and the immediate and late-phase reactions were enhanced in
IFN-g/ mice. As skin-infiltrating lymphocytes were scarce at the PCl-challenged site of IFN-g/ mice, we
investigated chemokine production by keratinocytes and Langerhans cells (LCs). A real-time PCR analysis
demonstrated that Th1 chemokines (CXCL9 and CXCL10) and Th2 chemokines (CCL17 and CCL22) were derived
mainly from keratinocytes and LCs, respectively. Challenge with PCl or FITC augmented keratinocyte expression
of Th1 chemokines in wild-type but not in IFN-g/mice, and Th2 chemokine production by LCs was induced by
repeated FITC in IFN-g/ mice. Finally, transfer of carboxyfluorescein diacetate succinimidyl ester (CFSE)-
labeled draining lymph node cells from hapten-sensitized B6 mice or lymph node cells from sensitized green
fluorescent protein (GFP) mice to naive IFN-g/ mice revealed less infiltration of CFSEþ or GFPþ lymphocytes
at the challenged site. Our study suggests that one of the crucial actions of IFN-g is upregulation of keratinocyte
production of Th1 chemokines and downregulation of LC production of Th2 chemokines.
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INTRODUCTION
IFN-g is one of the critical cytokines involved in cutaneous
hypersensitivity responses as well as in systemic immune
reactions. First, as a representative Th1 cytokine, IFN-g
supports CD8þ effector T cells that evoke contact hypersen-
sitivity (CHS) response (Bour et al., 1995; Xu et al., 1996),
graft-versus-host reaction (Blazar et al., 1998), and tumor
immunity (Seo and Tokura, 1999). Second, IFN-g upregulates
the immunological functions of keratinocytes, including
expression of CD54 (Griffiths et al., 1990), production of
proinflammatory cytokines such as IL-1a and tumor necrosis
factor (TNF)-a (Pastore et al., 1998), production of chemo-
kines such as IL-8, CCL5/RANTES (regulated upon activation,
normal T-cell expressed and secreted) (Li et al., 1996), and
Th1- and Th2-associated chemokines (Sebastiani et al.,
2002). Finally, IFN-g modulates the various functions of
Langerhans cells (LCs), including expression of major
histocompatibility complex class II and co-stimulatory
molecules (Salgado et al., 1999) and production of cytokines
and chemokines (Matsue et al., 1992).
Although knowledge regarding the in vitro effects of IFN-g on
skin immunocompetent cells has been thus accumulating, one
can realize that the in vivo actions of IFN-g have not extensively
been studied. For example, as a Th1 cytokine, systemic IFN-g
skews Th balance to Th1, and the treatment of Th2 disorders is
improved by IFN-g. However, patients with atopic dermatitis
are not necessarily alleviated by IFN-g (Stevens et al., 1998). In
another example, IFN-g promotes the in vitro production of Th2
chemokines by keratinocytes (Sebastiani et al., 2002), but it
remains unknown as to whether this seemingly ambivalent
phenomenon really occurs in in vivo settings. To resolve these
issues, in vivo studies using IFN-g-deficient mice are required.
Contact hypersensitivity belongs to the delayed-type
hypersensitivity (DTH), peaks at 24–48 hours after challenge,
and involves Th1/Tc1 cells (Akiba et al., 2002), cutaneous
dendritic cells (epidermal LCs and dermal dendritic cells)
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serving as antigen-presenting cells (Kissenpfennig and
Malissen, 2006), and keratinocytes producing IL-1a, TNF-a,
and GM-CSF (Heufler et al., 1998) stimulatory for LCs (Sugita
et al., 2007). However, when a given contactant is prone to
stimulate Th2 cells, certain responses earlier than DTH take
place and include immediate and late-phase reactions. The
immediate type occurs at 15minutes to 1 hour and is induced
by IgE and mast cells (Kitagaki et al., 1995), and the late-
phase reaction peaks at 4–8 hours and is mediated by Th2
cells and eosinophils (Dearman and Kimber, 2000; Ying
et al., 2002).
Chemokines derived from epidermal cells (ECs) are one of
the recent topics in CHS responses. Keratinocytes secrete Th1
chemokines, CXCL9/Mig and CXCL10/IP-10, and Th2
chemokines, CCL17/TARC and CCL22/MDC (Sebastiani
et al., 2002). IFN-g stimulates keratinocytes to produce both
Th1 and Th2 chemokines (Kakinuma et al., 2002; Sebastiani
et al., 2002). The stimulatory ability of IFN-g for Th1
chemokines appears to be reasonable, as a Th1-polarized
local response may be induced by IFN-g. However, its ability
to produce Th2 chemokines needs some sophisticated idea to
harmoniously construct sequential events. In contrast, LCs are
capable of producing Th2 and Th1 chemokines in vitro,
including CCL17, CCL22, CXCL10, CXCL9, and CXCL11/
I-TAC with Th2 chemokine dominancy. IFN-g is mostly
suppressive for the LC expression of Th2 chemokines, CCL17
and CCL22 (Fujita et al., 2005). Thus, IFN-g can modulate
both keratinocytes and LCs in their chemokine production
and in the resultant occurrence of CHS.
In this study, we addressed the role of IFN-g for the
immediate, late-phase, and delayed-type cutaneous hyper-
sensitivities by using IFN-g-knockout (IFN-g/) mice. As our
preliminary study showed the extent of skin infiltration of
lymphocytes was different between the wild-type and IFN-g/
mice, we focused on the effects of IFN-g on the chemokine
production by keratinocytes and LCs. Results suggest that Th1
and Th2 chemokines are produced mainly by keratinocytes
and LCs, respectively, and IFN-g upmodulates the production
of Th1 chemokines by keratinocytes but downmodulates the
production of Th2 chemokines by LCs, leading to the
reduction of cutaneous DTH response and the enhancement
of the early responses.
RESULTS
Reduced CHS response to 2,4,6-trinitrochlorobenzene
(picryl chloride) in IFN-c/ mice
Initially, we tested the degree of ordinary CHS response in
IFN-g/ mice along with wild-type C57BL/6J (B6) mice.
Mice were sensitized and challenged with picryl chloride
(PCl), and their ear swelling responses were measured
24 hours after challenge. A significant degree of ear swelling
response was observed in B6 but not in IFN-g/ mice, as
compared to the negative control mice challenged without
sensitization (Figure 1a). CHS responses to PCl were
monitored at 1, 4, and 24 hours after challenge. IFN-g/
mice did not exhibit a substantial swelling response through-
out the time course (Figure 1b). The ear swelling response of
B6 mice was reduced at 48 hours (7.0103 cm) compared
to that at 24 hours. No significant difference was observed in
the ear swelling of IFN-g/ mice between 24 and 48 hours
(data not shown).
Histologically, the intensity of inflammatory cell infiltrate
and dermal edema at the PCl-challenged site was lower in
IFN-g/ mice than in B6 mice (Figure 2a). When CD3þ
T cells in the dermis and subcutaneous tissue were
enumerated, T cells scarcely infiltrated in IFN-g/ mice
(Figure 2b). Thus, IFN-g/ mice lacked a capacity to develop
cutaneous DTH, and this inability was associated with the
absence of skin-infiltrating T cells.
Elevated immediate and late-phase reactions to repeatedly
challenged FITC in IFN-c/ mice
To evaluate whether IFN-g/ mice can develop early-phase
cutaneous reactions, we used the repeated hapten challenge
system, a known method to induce a Th2-mediated early skin
response (Kitagaki et al., 1997), with the use of Th2-skewing
hapten FITC (Dearman and Kimber, 2000). FITC was painted
one, three, or six times on the ears of B6 and IFN-g/ mice
that were sensitized with this hapten. The single challenge
with FITC did not elicit any ear swelling response at 1, 4, or
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Figure 1. CHS to PCl in B6 and IFN-c/ mice. (a) B6 and IFN-g/ mice were sensitized with 5% PCl on the shaved abdomen and challenged with 0.5%
PCl on the ears (PCl–PCl). Control mice were painted with vehicle alone and challenged with PCl (Veh-PCl). Ear thickness swelling was measured
24hours later. (b) The time course of ear swelling responses was monitored after elicitation with PCl in B6 and IFN-g/ mice. Data are expressed as the
mean±SD of six mice. *P¼ 0.0016, **P¼0.00029, and ***P¼ 0.0060.
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24 hours after challenge in either strain of mice (Figure 3a).
When challenged three times, significantly higher swelling
responses were found at 1 and 4hours in IFN-g/ mice than
in B6 mice (Figure 3b). There was no difference between the
two strains at 24 hours. The six-time challenge induced
similar but slightly higher levels of these reactions (data not
shown). The results suggested that IFN-g/ mice are prone to
develop immediate and late-phase cutaneous reactions
instead of DTH, suggesting a Th2-skewed immunological
state.
Augmentation of IL-4 expression by repeated FITC challenge in
immune lymph nodes of IFN-c/ mice
To confirm the preponderant expression of Th2 cytokines in
IFN-g/ mice, B6 and IFN-g/ mice were sensitized with
PCl or FITC, and challenged once with PCl or six times with
FITC, respectively. Cervical lymph nodes were taken from
these mice 24 hours after the last challenge, and IFN-g and IL-4
expressions were examined by real-time PCR. B6 mice had
IFN-g expression at a higher level by single challenge with
PCl than by repeated challenge with FITC, whereas IFN-g/
mice naturally exhibited no IFN-g expression (Figure 4). As
for IL-4, the repeated FITC challenge enhanced its expression
in both strains of mice as compared to PCl challenge, but the
level of enhancement by FITC was greatly higher in IFN-g/
mice than in B6 mice. These data indicated preferential
activation of Th2 cells in IFN-g/ mice after repeated FITC
challenge.
Infiltration of Th2 cells and presence of IgE and IL-4 at
repeatedly FITC-challenged skin of IFN-c/ mice
B6 and IFN-g/ mice were sensitized and challenged six
times with FITC, and their ears were histologically examined.
Both types of mice exhibited an inflammatory infiltrate
mainly in the dermis (Figure 5a). Some lymphocytes
infiltrated into the epidermis with spongiosis. Immunohisto-
chemically, IgE and IL-4 were present in IFN-g/ mice
presumably in association with mast cells and T cells,
respectively (Figure 5b).
Epidermal cell suspensions, including epidermotropic
lymphocytes as well as ECs, were prepared from the
challenged skin and subjected to real-time PCR analysis for
two chemokine receptors. CXCR3 is expressed mostly on Th1
cells, and CCR4 is preferentially on Th2 cells (Sebastiani et al.,
2002). Whereas CXCR3 was markedly expressed by FITC
challenge in B6 but not in IFN-g/ mice, CCR4 expression
was dramatically increased by repeated FITC painting in
IFN-g/ but not in B6 mice (Figure 6). Taken together with
the presence of IL-4 in IFN-g/ mice challenged with FITC,
this finding provides a possibility that IFN-g deficiency allows
Th2 cells to infiltrate into the skin, leading to the occurrence
of immediate and late-phase reactions.
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Figure 2. Histology and numbers of CD3þ T cells in PCl-challenged skin of B6 and IFN-c/ mice. (a) B6 and IFN-g/ mice were sensitized with 5% PCl and
challenged with 0.5% PCl. The challenged ears, along with no-treated ones (no Tx), were stained with hematoxylin and eosin. (b) Cryostat sections
of the challenged ears were immunohistochemically stained with anti-CD3 mAb, and CD3þ cells were enumerated in original magnification  500 field.
Data are expressed as the mean±SD of five mice. *P¼0.00018. Bar¼ 80 mm.
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Figure 3. Time course of ear swelling responses of B6 and IFN-c/ mice
receiving single-time or three time-elicitation with FITC. B6 and IFN-g/
mice were sensitized with 1% FITC on the abdomen and challenged with 0.5%
FITC once or thrice (3- to 4-day intervals) on the ears. One, four, and 24hours
after the final challenge, the ear swelling responses were measured. Data
are expressed as the mean±SD of five mice. *P¼ 0.0048, **P¼0.0060.
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Reduced CHS response to PCl in IFN-c/ mice receiving
adoptive transfer
Draining lymph node cells (5 106 cells) from wild-type B6
mice that were sensitized with PCl 5 days before were
labeled with carboxyfluorescein diacetate succinimidyl ester
(CFSE) and transferred to naive B6 or IFN-g/ mice.
Immediately after transfer, mice were challenged with PCl
on their ears. Although B6 mice transferred with sensitized
lymph node cells exhibited a significantly high ear swelling
response, IFN-g/ mice failed to respond to the challenge
(Figure 7a). This result clearly indicated impairment of the
efferent phase of CHS in IFN-g/ mice. When the ears of
mice receiving CFSE-labeled lymph node cells were histolo-
gically examined 24 hours after challenge, the number of
CFSE-positive cells in the ears of IFN-g/ mice was
significantly lower than that of B6 mice (Figure 7b).
To further confirm this paucity of infiltration, draining
lymph node cells (5 106 cells) from green fluorescent
protein (GFP) mice sensitized with DNFB 5 days before were
transferred to naive B6 or IFN-g/ mice. The recipients were
immediately challenged with DNFB. B6 but not IFN-g/
mice had a high ear swelling response (Figure 7c). Again,
histological examination at 24 hours after challenge showed
less infiltration of GFP-positive lymphocytes in IFN-g/ mice
(Figure 7d).
To test the participation of IFN-g in the afferent limb,
immune lymph node cells from B6 or IFN-g/ mice
sensitized with PCl were transferred to naive B6 mice, and
the recipient mice were challenged with PCl. The CHS
response of recipients receiving sensitized lymph node cells
of IFN-g/ mice was lower than that of mice receiving B6
lymph node cells (Figure 7e). This suggests that IFN-g is
involved in both induction and elicitation of CHS.
Reduction of Th1 chemokine production by keratinocytes in
IFN-c/ mice and enhancement of Th2 chemokine production
by LCs in IFN-c/ mice
Epidermal cell suspensions were obtained from the ears of B6
and IFN-g/ mice that were challenged once with PCl or six
times with FITC. Crude ECs were analyzed for EC-derived
chemokines. Both challenges with PCl and FITC elevated the
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Figure 4. Real-time PCR analysis of mRNA expression for cytokines in
cervical lymph node cells. B6 and IFN-g/mice were sensitized with 5% PCl
and challenged once with 0.5% PCl, or sensitized with 1% FITC and
challenged six times with 0.5% FITC (twice a week for 3 weeks). Single-cell
suspensions of immune cervical lymph node cells were prepared and
subjected to real-time PCR analysis for IFN-g and IL-4. Data are expressed as
the mean±SD of four mice. *Po0.05, **Po0.005.
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Figure 5. Histology and immunohistochemical stainings for IgE and IL-4 in
B6 and IFN-c/ mice receiving six times repeated elicitation with FITC. (a)
B6 and IFN-g/ mice were sensitized with 1% FITC and challenged with
0.5% FITC repeatedly six times (twice a week). The challenged ears were
stained with hematoxylin and eosin. (b) Cryostat sections of the challenged
ears were immunohistochemically stained with anti-IgE or anti-IL-4 mAb.
Bar¼50 mm.
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Figure 6. Real-time PCR analysis of mRNA expression for chemokine
receptors in skin-infiltrating cells. B6 and IFN-g/ mice were sensitized with
5% PCl and challenged once with 0.5% PCl, or sensitized with 1% FITC
and challenged six times with 0.5% FITC (twice a week for 3 weeks). Single-
cell suspensions of epidermal and dermal cells were prepared and subjected
to real-time PCR analysis for CXCR3 and CCR4. Data are expressed as the
mean±SD of four mice. *Po0.05, **Po0.005.
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expression of Th1 chemokine CXCL9 and CXCL10 in B6
mice, whereas such an augmentation was not found in
IFN-g/ mice (Figure 8, left). As for Th2 chemokines, PCl
challenge induced the expression of CCL17 and CCL22 in
both B6 and IFN-g/ mice. Repeated FITC challenge
augmented the expression of Th2 chemokines CCL17 and
CCL22 in IFN-g/, but FITC augmentation for CCL17 and
CCL22 was minimal in B6 mice. It was reported that CCL27/
CTACK-CCR10 signaling is an important regulator for skin
immune inflammation (Homey et al., 2002). Therefore,
CCL27 expression was also monitored, but there was no
substantial difference between challenged and non-treated
ears, or between B6 and IFN-g/ mice. Only marginal
increment was observed in IFN-g/ mice that were
challenged six times with FITC compared to non-treated
IFN-g/ mice (relative quantitative mRNA: 3.1 vs 1).
Accordingly, no enhanced expression of CCR10, a ligand
for CCL27, was found in PCl- or FITC-challenged skin of B6
or IFN-g/ mice.
When CD11cþ cells, namely LCs in the epidermis, were
depleted from crude EC suspensions, and again subjected to
real-time PCR analysis, signals of Th2 chemokines
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Figure 7. Adoptive transfer of CHS using immune lymph node cells labeled with CFSE and those from GFP mice. (a) Axillary, bradial, and inguinal lymph
node cells (5106 cells) of B6 mice that were sensitized 5% PCl on the shaved abdomen 5 days before were labeled with CFSE and transferred to naive B6 or
IFN-g/ mice. Immediately after transfer (tsf), mice were challenged with 10 ml of 0.5% PCl to both sides of ears (tsfþ ). Non-transferred B6 and IFN-g/ mice
were described as tsf. The increment of ear swelling was measured at 24 hours. (b) Ears of B6 and IFN-g/ mice receiving transfer of CFSE-labeled
immune lymph node cells from PCl-sensitized mice were taken 24hours after transfer and subjected to the histological study. The number of CFSE-positive
cells in the dermis was counted in six different original magnification  200 power fields and represented by the mean. (c) Immune lymph node cells were
prepared from GFP mice sensitized with 0.5% DNFB and transferred to naive B6 or IFN-g/mice. Mice were challenged with 10 ml of 0.3% DNFB to both sides
of ears (tsfþ ). Non-transferred mice were represented as tsf. The increment of ear swelling was measured at 24 hours. (d) Ears of B6 and IFN-g/ mice
receiving transfer of immune lymph node cells (5 106 cells) from DNFB-sensitized GFP mice were taken 24hours after transfer and subjected to the
histological study. The number of GFP-positive cells in the dermis was counted in six different original magnification  200 power fields and represented by the
mean. (e) Lymph node cells were prepared from B6 or IFN-g/ mice sensitized with 5% PCl and transferred to naive B6 mice. The recipient mice were
challenged with 10 ml of 0.5% PCl (B6, IFN-g/). The non-transferred mice represent the group of mice challenged alone. The ear thickness change was
measured at 24 hours. Data are expressed as the mean±SD of four mice. *Po0.001, **Po1.0 106, and ***Po0.05.
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Figure 8. Real-time PCR analysis of mRNA expression for chemokines in ECs. B6 and IFN-g/ mice were sensitized with PCl and challenged once with PCl, or
sensitized with FITC and challenged six times with FITC (twice a week for 3 weeks). Single-cell suspensions of epidermal cells were prepared from the
challenged ears. Unfractionated (crude ECs), CD11cþ cell-depleted (CD11c), and CD11cþ -purified ECs were subjected to real-time PCR analysis for Th1
chemokines (CXCL9 and CXCL10) and Th2 chemokines (CCL17 and CCL22). The expression of mRNA is represented as fold increase ð2DDCt Þ, where
DDCt¼ [DCt(sample)][DCt(B6 CD11c ECs without treatment)], and DCt¼ [Ct(sample)][Ct(b-actin)]. Data are expressed as the meanþ SD of four mice.
*Po0.03, compared between treated B6 mice or IFN-g/ mice, and no treatment B6 mice.
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disappeared, but those of Th1 chemokines remained (Fig-
ure 8, middle). Therefore, it was considered that Th1
chemokines are produced by keratinocytes, whereas Th2
chemokines are derived mainly from LCs.
The expression of Th2 chemokines, but not Th1 chemo-
kines, in LCs was confirmed with CD11cþ cell-purified ECs.
LCs from FITC or even PCl-challenged mice expressed Th2
chemokines but not Th1 chemokines (Figure 8, right). The
results indicated that IFN-g is required for keratinocyte
expression of Th1 chemokines, but suppressive for LC
expression of Th2 chemokines. IFN-g/ mice had the
decreased ability of keratinocytes to produce Th1 chemo-
kines even by PCl challenge, but retained the ability of LCs to
produce Th2 chemokines particularly upon repeated FITC
challenge.
DISCUSSION
In this study, we chose two distinct experimental systems to
discriminate Th1 and Th2 cutaneous hypersensitivity reac-
tions. The ordinary delayed-type CHS to PCl was used as a
Th1-mediated response, and the immediate or late-phase
reaction to repeatedly challenged FITC was used as a Th2-
mediated response. We investigated the differences between
the wild-type and IFN-g/ mice in these two cutaneous
hypersensitivity systems. IFN-g/ mice were low responders
in DTH to PCl, but high responders in the immediate and
late-phase responses to FITC. The Th1/Th2 dichotomy-related
immunological status was confirmed by the IFN-g expression
in PCl-challenged wild-type mice and the IL-4 expression in
FITC-challenged IFN-g/ mice.
The depression of DTH to PCl and the enhancement of
immediate and late-phase responses to FITC in IFN-g/ mice
are not particularly surprising, because the Th2-preponderant
immunological balance in these mice is easily expected as a
result of a relief from suppression of Th2 cells by IFN-g. In
addition, participation of IFN-g in both afferent and efferent
limbs duly results in depressed DTH. However, as inflam-
matory cells did not infiltrate in the PCl-challenged ears of
IFN-g/ mice, the observed downmodulation of cutaneous
DTH could not be simply attributable to the systemic
immunological shift to Th2 cells or to the impaired antigen-
presenting function of cutaneous dendritic cells, but the
failure in infiltration of T cells to the skin might be causative.
Conversely, the extent of inflammatory cell infiltrate in FITC-
challenged IFN-g/ mice was high. Therefore, chemokines
produced by ECs appeared to be critical for determining the
magnitude of these cutaneous responses.
Among ECs, keratinocytes and LCs are the essential
sources of chemokines (Sebastiani et al., 2002). CXCR3þ
Th1 cells infiltrated in the PCl-challenged B6 mice, whereas
CCR4þ Th2 cells were seen in the FITC-challenged IFN-g/
mice. Our real-time PCR analysis of EC-derived chemokines
revealed that Th1 chemokines, CXCL9 and CXCL10, are
produced by keratinocytes, and Th2 chemokines, CCL17 and
CCL22, are mainly exposed by LCs. In IFN-g/ mice, the
Th1 chemokines were not expressed by PCl challenge,
whereas the expression of Th2 chemokines retained when
challenged with PCl or FITC. Therefore, it is likely that IFN-g
is necessary for the production of Th1 chemokines by
keratinocytes, but unnecessary or rather suppressive for the
elaboration of Th2 chemokines by LCs. It is considered that
the lack of development of cutaneous DTH to PCl in IFN-g/
mice stems from the inability of keratinocytes to produce Th1
chemokines. In accordance with this finding, our transfer
study using immune lymph node cells obtained from
sensitized B6 mice and labeled with CFSE and those from
sensitized GFP mice demonstrated low infiltration of trans-
ferred lymphocytes in IFN-g/ mice.
The role of IFN-g for the production of CXCL9 and CXCL10
by keratinocytes has been reported (Albanesi et al., 2000b;
Mahalingam et al., 2001; Sebastiani et al., 2002). CCL17 and
CCL22 have also been reported to be released from keratino-
cytes (Sebastiani et al., 2002), and a combination of IFN-g and
TNF-a is one of the most effective stimuli for keratinocytes to
produce CCL17 and CCL22 (Kobayashi et al., 2004). However,
this study demonstrated that keratinocytes are not the main
source of these Th2 chemokines, but that LCs are the producers.
In accordance with this notion, cultured normal human
keratinocytes cannot produce CCL17 even under stimulation
with IFN-g and TNF-a (Tsuda et al., 2003). It has been reported
that LCs produce or express various chemokines, including
CCL17, CCL22, CXCL11, and CCL5 (Fujita et al., 2004, 2005).
Cytokines such as TNF-a, GM-CSF, IL-1b, and IL-4 stimulate
LCs to produce CCL17 and CCL22 (Soumelis et al., 2002). It is
notable that IFN-g is not a requirement for LCs to produce
CCL17 and CCL22 but rather suppressive for their production
(Xiao et al., 2003). In IFN-g/ mice, therefore, Th2 cells are
prone to infiltrate in the dermis, and the late-phase reaction
can occur as a result of successful migration of Th2 cells to
the skin. In this context, it is an interesting issue that the
infiltrating lymphocytes showed epidermotropism possibly
because of Th2 chemokine production by LCs. The produc-
tion of the chemokines by LCs may support the recent
concept that LCs are rather regulatory for the development of
CHS (Kaplan et al., 2005; Kissenpfennig et al., 2005).
Interferon-g, as well as IL-12 (Wolf et al., 1994), is the key
cytokine for Th1 responses. Furthermore, recent accumulat-
ing evidence has suggested the important role of IL-17 for
CHS (Nakae et al., 2002; He et al., 2006). As IL-17 stimulates
keratinocytes to release certain cytokines and chemokines
with synergistic or additive effects when used together in IFN-g
(Albanesi et al., 2000a), our results in IFN-g/ mice possibly
stem from the relief of the synergistic effects. Our study
suggests that IFN-g has a mandatory role for conditioning the
skin milieu by modulating Th1 and Th2 chemokines.
MATERIALS AND METHODS
Animals and chemicals
Eight to 10-week-old female B6 mice were purchased from Japan
SLC (Hamamatsu, Japan) and Kyudo Co. (Tosu, Japan). B6 and
IFN-g/ mice were obtained from Jackson Laboratory (Bar Harbor,
ME), and GFP mice were obtained from Japan SLC. These mice were
maintained in the Laboratory Animal Research Center in University
of Occupational and Environmental Health under specific pathogen-
free conditions. Female mice were used in this study. All animal
experiments were performed according to the guidelines for the care
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and use of animals approved by our university. PCl was purchased
from Tokyo Kasei (Tokyo, Japan), FITC from Sigma Chemical Co. (St
Louis, MO), and DNFB from Nakalai Tesque (Kyoto, Japan).
Sensitization and elicitation of CHS
For induction of CHS to PCl, mice were painted on the clipped
abdomen with 50 ml of 5% PCl in ethanol/acetone (3:1). Five days
after sensitization, mice were challenged by painting both sides of
each ear with 20 ml of 0.5% PCl in ethanol/acetone (3:1). The ear
thickness of mice was measured using dial thickness gauge (Ozaki
Co., Tokyo, Japan) before and 24 hours after challenge. Ear swelling
was calculated as (ear thickness after challenge)(ear thickness
before challenge).
For induction of CHS to FITC, mice were painted on the clipped
abdomen with 200 ml of 1% FITC in acetone/di-n-butylphthalate
(1:1). Five days after sensitization, mice were challenged by painting
both sides of each ear with 20ml of 0.5% FITC in acetone/di-
n-butylphthalate (1:1) twice a week for 3 weeks. The ear thickness of
mice was measured using dial thickness gauge before, 0, 1, 4, and
24 hours after challenge.
For induction of CHS to DNFB, mice were painted on the clipped
abdomen with 50ml of 0.5% DNFB in acetone/olive oil (4:1). The
ears were challenged with 20 ml of 0.3% DNFB in acetone/olive oil
(4:1).
Preparation of ECs, CD11cþ cell-depleted ECs, purified
CD11cþ ECs, and lymph node cells
Ears were obtained from mice 24 hours after the last challenge with
PCl or FITC, and epidermal and dermal skin was obtained by
removing cartilage and subcutaneous tissues. After incubation for
1 hour at 37 1C in a 0.2% solution of trypsin in PBS, the epidermis
was separated from the dermis, and ECs were dispersed in PBS
supplemented with 10% fetal calf serum (Gibco, Carlsbad, CA) by
rubbing the separated epidermal sheets (Tokura et al., 1994). The
cells were filtered through a cell strainer and washed twice in PBS. In
some experiments, CD11cþ ECs were purified with automagnetic-
activated cell sorting (Miltenyi Biotec, Bergisch Gladbach, Ger-
many). After ECs were incubated with RPMI 1640 supplemented
with 10% fetal calf serum for 30minutes, ECs were first reacted with
CD11c microbeads (120-000-322; Miltenyi Biotec) for 30minutes
and selected for CD11cþ ECs, representing LCs. The purity of
CD11cþ cells was 70–80% (Sugita et al., 2007). After removing
CD11cþ cells, CD11c ECs were obtained and CD11cþ cells were
less than 0.1%. Among CD11c-positive fractionated cells from ECs,
more than 99% of CD11cþ cells were Langerin (eBioscience, San
Diego, CA) positive (data not shown).
B6 and IFN-g/ mice were sensitized with 5% PCl and
challenged once with 0.5% PCl, or sensitized with 1% FITC and
challenged six times with 0.5% FITC (twice a week for 3 weeks).
Single-cell suspensions of immune cervical lymph node cells were
prepared from the treated mice.
Histological assessment
Twenty-four hours after challenge with PCl and FITC, mice were
killed by cervical dislocation and ears were amputated. The ears
were fixed with formalin and embedded in paraffin. Two- to three-
micrometer- thick sections were cut and stained with hematoxylin
and eosin. An indirect immunohistochemical staining was
performed. The first antibodies included anti-CD3 (clone KT3, rat
IgG2a; Chemicon, Billerica, MA), anti-IgE (clone 23G3, rat IgG1K;
eBioscience), and IFN-g (clone XMG1.2, rat IgG1K; eBioscience) and
mAbs. A goat anti-rat IgG antibody conjugated with horseradish
peroxidase was used as the second antibody, and reaction was
visualized with diaminobenzidine.
Adoptive transfer
B6 mice were sensitized with 50ml of 5% PCl in ethanol/acetone
(3:1) on the clipped abdomen. Five days after sensitization, the
axillary, bradial, and inguinal lymph nodes were removed, single-
cell suspensions were prepared and labeled with 6.5 mM CFSE
(Molecular Probes, Eugene, OR). The cells resuspended in RPMI
containing 0.2% fetal calf serum were injected intravenously to
naive B6 mice or naive IFN-g/ mice (5 106 cells per mouse).
Immediately after the cell transfer, the ears were challenged with
20 ml of 0.5% PCl in ethanol/acetone (3:1), and the increase in ear
swelling was measured 24 hours later. In parallel, ears of transferred
B6 and IFN-g/ mice were histologically examined 24 hours after
cell transfer. CFSE-positive cells in about 7 mm ear section of each
mouse were counted.
In another transfer study, GFP mice were sensitized with 50 ml of
0.5% DNFB in acetone/olive oil (4:1). Five days later, the immune
lymph node cells were prepared as above and injected intravenously
to naive B6 mice or naive IFN-g/ mice (5 106 cells per mouse).
The ears were challenged with 20 ml of 0.3% DNFB in acetone/olive
oil (4:1). The ear swelling response, histology, and GFP-positive cells
were examined as above.
Real-time quantitative PCR
Total cellular RNA was extracted with an RNA extraction kit
(Promega, Madison, WI) from freshly prepared skin samples. RNA
was then reverse-transcribed and amplified by random hexamer in
single-tube assay using the TaqMan Reverse Transcription Reagants
(Applied Biosystems, Foster City, CA) with gene-specific sense and
antisense primers and a detection probe labeled on the 50-end with
the reporter dye 6-FAM. Primers and probes were obtained from
TaqMan Gene Expression Assays Inventories (Applied Biosystems).
Using an ABI Prism 7000 Sequence Detection Systems (Applied
Biosystems), duplicate samples were reverse-transcribed and ampli-
fied under the following consecutive steps: 2minutes at 50 1C,
10minutes at 95 1C, followed by 50 amplification cycles of
15 seconds at 95 1C and 1minute at 60 1C. Sequence-specific
amplification was detected as an increased fluorescent signal of
6-FAM exceeding the threshold limit during the amplification cycle.
Quantification of gene-specific message levels was determined by
comparing fluorescence intensity from unknown RNA samples to the
fluorescence intensity of standard curve generated from control
mRNA levels. Amplification of the gene for mouse b-actin was
performed on all samples to control interspecimen variations in RNA
amounts. The result for each gene was normalized to the quantity of
mouse b-actin detected in the sample. Levels of gene-specific
message were graphed as normalized message units as determined
from standard curve.
Statistical analysis
Data were analyzed using an unpaired two-tailed t-test. Po0.05 was
considered to be significant.
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